CICC China Equity Fund
Calender Year Past Performance
Calendar Year Performance 2019 2020 2021 2022 2023
Sub-Fund         -17.6%

* Sub-Fund Inception Date: 21 July 2022

Past performance information is not indicative of future performance. Investors may not get back the full amount invested.

The computation basis of the performance is based on the calendar year end, NAV-to-NAV, with dividends reinvested.

These figures show by how much the fund increased or decreased in value during the period shown.

Performance data has been calculated in HKD including on-going charges and excluding subscription fee and redemption fee you might have to pay.

Where no past performance is shown there was insufficient data available in that year to provide performance.

Source: China International Capital Corporation Hong Kong Asset Management Limited, Bloomberg 

 

General risk warning: 

• Investment involves risk, including possible loss of principal. There can be no assurance that the Sub-Fund will achieve its stated objectives. Past performance is not indicative of future performance. 

• Carefully consider the Sub-Fund’s investment objectives, risk factors, charges and expenses before investing. Additional information can be found in the Sub-Fund’s Prospectus and Product Key Facts Statement of the Sub-Fund (together, the “Offering Documents”).

• You should not make any investment decision based on the information as per above.  Read the Offering Documents carefully before investing. The Offering Documents should be read for further details including the risk factors.

• Nothing contained in this wesbite constitutes investment advice or should be relied on as such. This wesbite has not been reviewed by the Securities and Futures Commission of Hong Kong (SFC). The Sub-Fund has been authorised as collective investment schemes by the SFC. SFC authorisation is not a recommendation or endorsement of a scheme nor does it guarantee the commercial merits of a scheme or its performance. It does not mean the scheme is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors.